Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Mar 5, 2010

Premium

Adrian Dillon is stepping down as executive vice president and chief financial officer at Agilent Techologies, effective April 1, the company said this week. He will be replaced by Didier Hirsch.

Dillon is joining internet phone company Skype as CFO and administration officer.
He joined Agilent in December 2001 and has been responsible for managing the company's finance functions, strategic planning, and corporate development, as well as sharing in administrative services, including information technology and global sourcing.

Hirsch is presently vice president, corporate controllership and tax at Agilent and has been with the company since its founding in 1999. Prior to joining Agilent, he was CFO of Hewlett-Packard Europe, Middle East, and Africa.


Vermillion said this week that Carl Severinghaus has been appointed to its board.

Severinghaus is currently with Tecan, where he has held a number of different management positions, including president of Tecan Americas since last year. He is responsible for sales and operations for the Americas sales region.


Patrik Bjöörn has joined Denator as an application specialist, the Swedish sample prep firm said this week.

He will be responsible for technical support. Bjöörn joins Denator from Biolin Scientific where he was a senior sales and application specialist. Before that he was at Q-Sense as a sales director and president of the company's US branch.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.